LI-RADS — What It Means on Your Imaging Report
Quick Answer
LI-RADS (LR-1 to LR-5, plus LR-M, LR-TIV, LR-NC) is a scoring system used on liver CT and MRI in patients at high risk for liver cancer — the category tells your doctor what to do next.
What Is LI-RADS?
LI-RADS stands for Liver Imaging Reporting and Data System. It was developed by the American College of Radiology (ACR) so that every radiologist describes liver findings the same way and recommends the same next step. The current CT/MRI diagnostic algorithm is ACR LI-RADS v2018.
LI-RADS is used only on liver CT or MRI in people considered at high risk for HCC, or hepatocellular carcinoma — a type of liver cancer. In practice, that means people with cirrhosis — long-term scarring of the liver, people with chronic hepatitis B — a long-term liver infection caused by the hepatitis B virus, or people with a current or prior HCC. It is not applied to the general population, and it is not used for liver findings discovered incidentally in low-risk patients.
The category itself is not a final diagnosis. It is a structured way to say how likely a specific liver observation is to be HCC, and what action to take next.
Categories / Classification
| LI-RADS Category | What It Means | Recommended Action |
|---|---|---|
| LR-1 | Definitely benign — for example, a clearly typical cyst or hemangioma (a benign blood vessel growth) | No additional liver workup for this observation. Continue routine HCC surveillance imaging on the usual schedule |
| LR-2 | Probably benign | No biopsy. Continue routine HCC surveillance imaging on the usual schedule |
| LR-3 | Intermediate probability of malignancy — not a cancer diagnosis | Short-interval follow-up imaging, typically in about 3–6 months. Biopsy is not automatic |
| LR-4 | Probably HCC, but features are not fully diagnostic | A team of specialists — usually a radiologist, a liver specialist, and an oncologist — reviews your case together. Options usually include short-interval follow-up imaging (often ~3 months), repeat imaging with a different technique, or biopsy — biopsy is not automatic |
| LR-5 | Definitely HCC by imaging criteria | Treatment planning by the liver team. The imaging features are so specific to HCC that they are very rarely wrong, so in the right clinical context treatment can sometimes proceed without a biopsy |
| LR-M | Probably or definitely malignant, but the imaging features are not specific for HCC (could be a different liver cancer) | Biopsy is usually recommended to identify the exact tumor type |
| LR-TIV | Tumor in vein — tumor tissue seen inside a liver blood vessel | Urgent referral to the liver team for staging and treatment planning |
| LR-NC | Not categorizable — the images are limited (for example, motion or missing phases) and the observation cannot be scored | Repeat or additional imaging is needed before a category can be given |
When You Might See This on Your Report
You will only see LI-RADS on certain liver scans:
- Liver CT with contrast done as part of HCC surveillance or workup
- Liver MRI with contrast done as part of HCC surveillance or workup
- Reports written for patients who are already known to be at high risk for HCC — typically people with cirrhosis, chronic hepatitis B, or a history of HCC
If your liver CT or MRI was done for a different reason and you are not in an HCC-surveillance population, your report may describe the same finding without using an LR- category. In that case, LI-RADS likely does not apply to your situation.
The LI-RADS category usually appears in the Impression section of the report, next to the description of the liver observation.
Should I Be Worried?
It depends on the category, and the most common misunderstanding is about LR-3 and LR-5.
- LR-1 and LR-2 are reassuring — the radiologist is essentially saying this observation is benign and does not need its own workup.
- LR-3 is intermediate, not malignant. LR-3 does not mean cancer. It means the imaging features fall in a middle zone where short-interval follow-up imaging (often about 3–6 months) is the standard next step — not biopsy. Many LR-3 observations stay stable or shrink on follow-up.
- LR-4 means the radiologist thinks HCC is likely but the imaging is not fully diagnostic. Next steps are discussed by the liver team and may include more imaging or biopsy.
- LR-5 has very high specificity for HCC. That means when the imaging meets LR-5 criteria, the chance the observation truly is HCC is very high. In the right clinical context — for example, a patient with cirrhosis being followed by a liver team — treatment can sometimes proceed without a biopsy. This is honest information about how confident the imaging is, not a reason to panic; it also explains why your doctor may move quickly to discuss treatment options.
- LR-M, LR-TIV, and LR-NC are special cases that always need follow-up with the liver team rather than self-interpretation.
LI-RADS only applies in HCC-surveillance populations. If you got a liver CT or MRI for an unrelated reason (for example, kidney stones or abdominal pain), this system may not apply to your case at all, even if a liver finding was mentioned.
What Should I Do Next?
- Find the LR- category in the Impression section of your report (for example, "LR-3" or "LR-5") and write it down exactly as it is written.
- Confirm whether you are in a high-risk-for-HCC group. LI-RADS is designed for people with cirrhosis, chronic hepatitis B, or a current or prior HCC. Ask the doctor who manages your liver care — often a hepatologist (a doctor who specialises in liver conditions) or gastroenterologist — whether you fall into one of these groups.
- Ask your doctor to walk you through the specific category they saw on your report, what it means in your situation, and what the plan is.
- Clarify the follow-up imaging interval. For LR-3 and LR-4, the timing of the next scan (often 3 or 6 months) is a key part of the plan — make sure you know the date and the type of scan.
- Do not assume LR-5 has been "confirmed" only with imaging. If your doctor recommends a biopsy or recommends moving to biopsy-free treatment, ask why that decision was made in your case, and what the next steps would be either way.